| 0 (0%) | 09-27 11:15 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 308.42 | 1-year : | 360.23 |
| Resists | First : | 264.05 | Second : | 308.42 |
| Pivot price | 255.93 |
|||
| Supports | First : | 250.2 |
Second : | 241.63 |
| MAs | MA(5) : | 255.79 |
MA(20) : | 253.84 |
| MA(100) : | 232.37 |
MA(250) : | 262.29  |
|
| MACD | MACD : | 3.3 |
Signal : | 3.4 |
| %K %D | K(14,3) : | 68.8 |
D(3) : | 59.1 |
| RSI | RSI(14): 59.6 |
|||
| 52-week | High : | 352.32 | Low : | 187.42 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ WST ] has closed below upper band by 10.8%. Bollinger Bands are 41.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 263.12 - 264.98 | 264.98 - 266.42 |
| Low: | 251.32 - 253.27 | 253.27 - 254.79 |
| Close: | 258.95 - 262 | 262 - 264.36 |
Thu, 25 Sep 2025
Riverbridge Partners LLC Trims Stock Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Thu, 25 Sep 2025
Norden Group LLC Sells 1,432 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Thu, 25 Sep 2025
Counterpoint Mutual Funds LLC Invests $328,000 in West Pharmaceutical Services, Inc. $WST - MarketBeat
Wed, 24 Sep 2025
West Pharmaceutical Services (WST) Stock Is Up, What You Need To Know - FinancialContent
Mon, 15 Sep 2025
New Analyst Forecast: $WST Given $311.0 Price Target - Quiver Quantitative
Thu, 24 Jul 2025
West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 72 (M) |
| Shares Float | 71 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 98.3 (%) |
| Shares Short | 1,530 (K) |
| Shares Short P.Month | 2,170 (K) |
| EPS | 6.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 40.74 |
| Profit Margin | 16.4 % |
| Operating Margin | 20.8 % |
| Return on Assets (ttm) | 10.5 % |
| Return on Equity (ttm) | 17.7 % |
| Qtrly Rev. Growth | 9.1 % |
| Gross Profit (p.s.) | 14.46 |
| Sales Per Share | 41.16 |
| EBITDA (p.s.) | 10.97 |
| Qtrly Earnings Growth | 20.5 % |
| Operating Cash Flow | 677 (M) |
| Levered Free Cash Flow | 208 (M) |
| PE Ratio | 39.14 |
| PEG Ratio | 0 |
| Price to Book value | 6.41 |
| Price to Sales | 6.35 |
| Price to Cash Flow | 27.79 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|